NCT02825992View on ClinicalTrials.gov

Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

October 17, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

May 15, 2018

Conditions
Persistent Atrial Fibrillation
Interventions
DEVICE

AcQMap System

3D imaging and mapping system for cardiac chambers

Trial Locations (12)

10967

Vivantes Klinikum Am Urban, Berlin

20100

Centro Cardiologico Monzino, Milan

L3Y 2P9

Southlake Regional Health Center, Newmarket

150 30

Na Homolce Hospital, Prague

D-50937

Herzzentrum der Universität zu Köln, Cologne

Unknown

Universitätsklinikum Hamburg-Eppendorf, Hamburg

Papworth Hospital, Cambridge

6229 HX

Maastricht University Medical Center, Maastricht

3435 CM

St. Antonius Hospital, Nieuwegein

NE7 7DN

Freeman Hospital, Newcastle

SW3 6NP

Royal Brompton Hospital, London

OX3 9DU

John Radcliffe Hospital, Oxford

Sponsors

Lead Sponsor

Acutus Medical
All Listed Sponsors
lead

Acutus Medical

INDUSTRY

NCT02825992 - Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation | Biotech Hunter | Biotech Hunter